MARIA TERESA
BERNAL DEL CASTILLO
Profesora Titular de Universidad
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, España
Publications in collaboration with researchers from Hospital Universitario Nuestra Señora de Candelaria (6)
2025
-
AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular
Blood Advances, Vol. 9, Núm. 1, pp. 39-53
-
Autologous or Allogeneic Hematopoietic Stem Cell Transplantation as Front-Line Treatment for Adult Secondary Acute Myeloid Leukemia Patients: The PETHEMA Registry Experience
Transplantation and Cellular Therapy, Vol. 31, Núm. 5, pp. 299.e1-299.e14
-
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA Study
Cancers, Vol. 17, Núm. 5
2024
-
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
Haematologica, Vol. 109, Núm. 1, pp. 115-128
-
Validation of mutated CEBPA bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registry
Haematologica
2022
-
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study
Blood Advances, Vol. 6, Núm. 4, pp. 1278-1295